Skip to main content
Erschienen in: CardioVascular and Interventional Radiology 5/2017

03.01.2017 | Laboratory Investigation

New Alcohol and Onyx Mixture for Embolization: Feasibility and Proof of Concept in Both In Vitro and In Vivo Models

verfasst von: Mohammad Saeed Kilani, Fatemeh Zehtabi, Sophie Lerouge, Gilles Soulez, Jean Michel Bartoli, Vincent Vidal, Mohammad F. Badran

Erschienen in: CardioVascular and Interventional Radiology | Ausgabe 5/2017

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Onyx and ethanol are well-known embolic and sclerotic agents that are frequently used in embolization. These agents present advantages and disadvantages regarding visibility, injection control and penetration depth. Mixing both products might yield a new product with different characteristics. The aim of this study is to evaluate the injectability, radiopacity, and mechanical and occlusive properties of different mixtures of Onyx 18 and ethanol in vitro and in vivo (in a swine model).

Materials and Methods

Various Onyx 18 and ethanol formulations were prepared and tested in vitro for their injectability, solidification rate and shrinkage, cohesion and occlusive properties. In vivo tests were performed using 3 swine. Ease of injection, radiopacity, cohesiveness and penetration were analyzed using fluoroscopy and high-resolution CT.

Results

All mixtures were easy to inject through a microcatheter with no resistance or blockage in vitro and in vivo. The 50%-ethanol mixture showed delayed copolymerization with fragmentation and proximal occlusion. The 75%-ethanol mixture showed poor radiopacity in vivo and was not tested in vitro. The 25%-ethanol mixture showed good occlusive properties and accepted penetration and radiopacity.

Conclusion

Mixing Onyx and ethanol is feasible. The mixture of 25% of ethanol and 75% of Onyx 18 could be a new sclero-embolic agent. Further research is needed to study the chemical changes of the mixture, to confirm the significance of the added sclerotic effect and to find out the ideal mixture percentages.
Literatur
1.
Zurück zum Zitat Cho SK, Do YS, Shin SW, Kim D-I, Kim YW, Park KB, et al. Arteriovenous malformations of the body and extremities: analysis of therapeutic outcomes and approaches according to a modified angiographic classification. J Endovasc Ther. 2006;13:527–38.CrossRefPubMed Cho SK, Do YS, Shin SW, Kim D-I, Kim YW, Park KB, et al. Arteriovenous malformations of the body and extremities: analysis of therapeutic outcomes and approaches according to a modified angiographic classification. J Endovasc Ther. 2006;13:527–38.CrossRefPubMed
2.
Zurück zum Zitat Do YS, Yakes WF, Shin SW, Lee B-B, Kim D-I, Liu WC, et al. Ethanol embolization of arteriovenous malformations: interim results 1. Radiology. 2005;235:674–82.CrossRefPubMed Do YS, Yakes WF, Shin SW, Lee B-B, Kim D-I, Liu WC, et al. Ethanol embolization of arteriovenous malformations: interim results 1. Radiology. 2005;235:674–82.CrossRefPubMed
3.
Zurück zum Zitat Jin Y, Lin X, Li W, Hu X, Ma G, Wang W. Sclerotherapy after embolization of draining vein: a safe treatment method for venous malformations. J Vasc Surg. 2008;47:1292–9.CrossRefPubMed Jin Y, Lin X, Li W, Hu X, Ma G, Wang W. Sclerotherapy after embolization of draining vein: a safe treatment method for venous malformations. J Vasc Surg. 2008;47:1292–9.CrossRefPubMed
5.
Zurück zum Zitat Gomes AS. Embolization therapy of congenital arteriovenous malformations: use of alternate approaches. Radiology. 1994;190:191–8.CrossRefPubMed Gomes AS. Embolization therapy of congenital arteriovenous malformations: use of alternate approaches. Radiology. 1994;190:191–8.CrossRefPubMed
6.
Zurück zum Zitat Do YS, Park K-B, Cho SK. How do we treat arteriovenous malformations (tips and tricks)? Tech Vasc Interv Radiol. 2007;10:291–8.CrossRefPubMed Do YS, Park K-B, Cho SK. How do we treat arteriovenous malformations (tips and tricks)? Tech Vasc Interv Radiol. 2007;10:291–8.CrossRefPubMed
7.
Zurück zum Zitat Houbballah R, Mallios A, Poussier B, Soury P, Fukui S, Gigou F, et al. A new therapeutic approach to congenital pelvic arteriovenous malformations. Ann Vasc Surg. 2010;24:1102–9.CrossRefPubMed Houbballah R, Mallios A, Poussier B, Soury P, Fukui S, Gigou F, et al. A new therapeutic approach to congenital pelvic arteriovenous malformations. Ann Vasc Surg. 2010;24:1102–9.CrossRefPubMed
8.
Zurück zum Zitat Jeong H-S, Baek C-H, Son Y-I, Wook Kim T, Bung Lee B, Sik Byun H. Treatment for extracranial arteriovenous malformations of the head and neck. Acta Otolaryngol (Stockh). 2006;126:295–300.CrossRef Jeong H-S, Baek C-H, Son Y-I, Wook Kim T, Bung Lee B, Sik Byun H. Treatment for extracranial arteriovenous malformations of the head and neck. Acta Otolaryngol (Stockh). 2006;126:295–300.CrossRef
9.
Zurück zum Zitat Kademani D, Costello BJ, Ditty D, Quinn P. An alternative approach to maxillofacial arteriovenous malformations with transosseous direct puncture embolization. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;97:701–6.CrossRefPubMed Kademani D, Costello BJ, Ditty D, Quinn P. An alternative approach to maxillofacial arteriovenous malformations with transosseous direct puncture embolization. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;97:701–6.CrossRefPubMed
10.
Zurück zum Zitat Jackson JE, Mansfield AO, Allison DJ. Treatment of high-flow vascular malformations by venous embolization aided by flow occlusion techniques. Cardiovasc Intervent Radiol. 1996;19:323–8.CrossRefPubMed Jackson JE, Mansfield AO, Allison DJ. Treatment of high-flow vascular malformations by venous embolization aided by flow occlusion techniques. Cardiovasc Intervent Radiol. 1996;19:323–8.CrossRefPubMed
11.
Zurück zum Zitat Loh Y, Duckwiler GR. Onyx trial investigators. A prospective, multicenter, randomized trial of the Onyx liquid embolic system and N-butyl cyanoacrylate embolization of cerebral arteriovenous malformations. Clinical article. J Neurosurg. 2010;113:733–41.CrossRefPubMed Loh Y, Duckwiler GR. Onyx trial investigators. A prospective, multicenter, randomized trial of the Onyx liquid embolic system and N-butyl cyanoacrylate embolization of cerebral arteriovenous malformations. Clinical article. J Neurosurg. 2010;113:733–41.CrossRefPubMed
12.
Zurück zum Zitat Ayad M, Eskioglu E, Mericle RA. Onyx: a unique neuroembolic agent. Expert Rev Med Devices. 2006;3:705–15.CrossRefPubMed Ayad M, Eskioglu E, Mericle RA. Onyx: a unique neuroembolic agent. Expert Rev Med Devices. 2006;3:705–15.CrossRefPubMed
13.
Zurück zum Zitat Saeed Kilani M, Izaaryene J, Cohen F, Varoquaux A, Gaubert JY, Louis G, et al. Ethylene vinyl alcohol copolymer (Onyx®) in peripheral interventional radiology: indications, advantages and limitations. Diagn Interv Imaging. 2015;96:319–26.CrossRefPubMed Saeed Kilani M, Izaaryene J, Cohen F, Varoquaux A, Gaubert JY, Louis G, et al. Ethylene vinyl alcohol copolymer (Onyx®) in peripheral interventional radiology: indications, advantages and limitations. Diagn Interv Imaging. 2015;96:319–26.CrossRefPubMed
14.
Zurück zum Zitat Ambekar S, Gaynor BG, Peterson EC, Elhammady MS. Long-term angiographic results of endovascularly “cured” intracranial dural arteriovenous fistulas. J Neurosurg. 2016;124:1123–7.CrossRefPubMed Ambekar S, Gaynor BG, Peterson EC, Elhammady MS. Long-term angiographic results of endovascularly “cured” intracranial dural arteriovenous fistulas. J Neurosurg. 2016;124:1123–7.CrossRefPubMed
15.
Zurück zum Zitat Jacobowitz GR, Rosen RJ, Rockman CB, Nalbandian M, Hofstee DJ, Fioole B, et al. Transcatheter embolization of complex pelvic vascular malformations: results and long-term follow-up. J Vasc Surg. 2001;33:51–5.CrossRefPubMed Jacobowitz GR, Rosen RJ, Rockman CB, Nalbandian M, Hofstee DJ, Fioole B, et al. Transcatheter embolization of complex pelvic vascular malformations: results and long-term follow-up. J Vasc Surg. 2001;33:51–5.CrossRefPubMed
16.
Zurück zum Zitat Soulez G, Lerouge S, Darsaut T, Salazkin I, Oliva VL, Raymond J. Role of the endothelial lining in endoleak formation and persistence after endovascular repair of aneurysm. J Vasc Interv Radiol. 2008;19:1070–8.CrossRefPubMed Soulez G, Lerouge S, Darsaut T, Salazkin I, Oliva VL, Raymond J. Role of the endothelial lining in endoleak formation and persistence after endovascular repair of aneurysm. J Vasc Interv Radiol. 2008;19:1070–8.CrossRefPubMed
17.
Zurück zum Zitat Albanese G, Kondo KL. Pharmacology of sclerotherapy. Semin Interv Radiol. 2010;27:391–9.CrossRef Albanese G, Kondo KL. Pharmacology of sclerotherapy. Semin Interv Radiol. 2010;27:391–9.CrossRef
18.
Zurück zum Zitat Hyodoh H, Hori M, Akiba H, Tamakawa M, Hyodoh K, Hareyama M. Peripheral vascular malformations: imaging, treatment approaches, and therapeutic issues. Radiographics. 2005;25:S159–71.CrossRefPubMed Hyodoh H, Hori M, Akiba H, Tamakawa M, Hyodoh K, Hareyama M. Peripheral vascular malformations: imaging, treatment approaches, and therapeutic issues. Radiographics. 2005;25:S159–71.CrossRefPubMed
19.
Zurück zum Zitat Ellman BA, Parkhill BJ, Marcus PB, Curry TS, Peters PC. Renal ablation with absolute ethanol. Mechanism of action. Invest Radiol. 1984;19:416–23.CrossRefPubMed Ellman BA, Parkhill BJ, Marcus PB, Curry TS, Peters PC. Renal ablation with absolute ethanol. Mechanism of action. Invest Radiol. 1984;19:416–23.CrossRefPubMed
20.
Zurück zum Zitat Yakes WS, Parker SH. Diagnosis and management of vascular anomalies. Interv Radiol. Baltimore: Williams and Wilkins; 1992. p. 152–89. Yakes WS, Parker SH. Diagnosis and management of vascular anomalies. Interv Radiol. Baltimore: Williams and Wilkins; 1992. p. 152–89.
21.
Zurück zum Zitat Do YS, Park KB, Park HS, Cho SK, Shin SW, Moon JW, et al. Extremity arteriovenous malformations involving the bone: therapeutic outcomes of ethanol embolotherapy. J Vasc Interv Radiol JVIR. 2010;21:807–16.CrossRefPubMed Do YS, Park KB, Park HS, Cho SK, Shin SW, Moon JW, et al. Extremity arteriovenous malformations involving the bone: therapeutic outcomes of ethanol embolotherapy. J Vasc Interv Radiol JVIR. 2010;21:807–16.CrossRefPubMed
22.
Zurück zum Zitat Katz JM, Gobin YP, Riina HP. Interv Neuroradiol. New York: Informa; 2008. p. 161–82. Katz JM, Gobin YP, Riina HP. Interv Neuroradiol. New York: Informa; 2008. p. 161–82.
23.
Zurück zum Zitat Fatimi A, Chabrot P, Berrahmoune S, Coutu J-M, Soulez G, Lerouge S. A new injectable radiopaque chitosan-based sclerosing embolizing hydrogel for endovascular therapies. Acta Biomater. 2012;8:2712–21.CrossRefPubMed Fatimi A, Chabrot P, Berrahmoune S, Coutu J-M, Soulez G, Lerouge S. A new injectable radiopaque chitosan-based sclerosing embolizing hydrogel for endovascular therapies. Acta Biomater. 2012;8:2712–21.CrossRefPubMed
Metadaten
Titel
New Alcohol and Onyx Mixture for Embolization: Feasibility and Proof of Concept in Both In Vitro and In Vivo Models
verfasst von
Mohammad Saeed Kilani
Fatemeh Zehtabi
Sophie Lerouge
Gilles Soulez
Jean Michel Bartoli
Vincent Vidal
Mohammad F. Badran
Publikationsdatum
03.01.2017
Verlag
Springer US
Erschienen in
CardioVascular and Interventional Radiology / Ausgabe 5/2017
Print ISSN: 0174-1551
Elektronische ISSN: 1432-086X
DOI
https://doi.org/10.1007/s00270-016-1559-z

Weitere Artikel der Ausgabe 5/2017

CardioVascular and Interventional Radiology 5/2017 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.